STOK
Stoke Therapeutics Inc
24.80$
-1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -119.3% | – | – | – | – | – | |
| – | -2.0% | -9.8% | -2.7% | -1.5% | -2.6% | -9.3% | -6.5% | +121.7% | -59.0% | +8.4% | +4.3% | – | |
| – | -8.9% | -9.0% | +34.8% | +2.2% | -6.0% | -5.4% | +12.5% | +5.8% | +22.5% | -11.1% | +23.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -3,462.7% | – | -195.8% | – | – | -217.9% | – | – | |
| – | -40.2% | -94.8% | +283.3% | +123.9% | -59.2% | +261.9% | +1.3% | -14.3% | +75.8% | +52.2% | +459.8% | – | |
| – | +1.1% | -32.4% | -983.8% | -66.0% | – | +1,564.5% | -1,189.2% | – | -771.4% | – | -82.2% | – | |
| – | +1,206.6% | -76.6% | +6,926.8% | -93.2% | -93.0% | +141.9% | -59.7% | +463.2% | +2,859.6% | -8.7% | -97.7% | – | |
| – | – | -977.9% | – | -391.8% | – | – | -218.1% | – | – | +8,912.0% | -161.3% | – | |
| – | – | – | – | – | – | – | -119.4% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.